Indication and assessment for liver transplantation.
نویسندگان
چکیده
In chronic liver disease the most important aspect of patient selection is timing. Transplantation should improve both quality and quantity of life. The procedure is optimally carried out when the patient is well enough to withstand the procedure, but ill enough to warrant it (ie predicted survival is about 1–2 years without a transplant). Assessment for transplantation in chronic liver disease is difficult. Objective and subjective measures are used. The Child-Pugh classification2 (Table 1) allows objective assessment of a patient’s functional liver status and in the USA forms the basis for the criteria required to list patients. Those with Childs C grade have a 58%, 21% and 0% one-year, five-year and 10-year survival, respectively. Subjective measures of liver disease may be more difficult to assess. Tools are available to document quality of life3, and a full psychosocial assessment should be carried out.
منابع مشابه
پیوند کبد
However, history of liver transplantation has started in 1963, but after discovery of anti-rejection drugs such as cyclosporine in 1980s, this method has experienced. From 1984 more than 3000 patients underwent surgery and just 1680 patients in 66 liver transplantation centers have operated in 1988. Every patient suffers from severe liver diseases and is in terminal stage of this disease, must ...
متن کاملSeverity Assessment of Chronic Liver Disease in Children
Introduction: Chronic liver disease and cirrhosis are the most important causes of growth failure, morbidity and mortality in children. Cirrhosis consists of a variety of congenital, genetic, metabolic, and infectious causes in children. Models for predicting of chronic liver disease severity, survival, and transplantation are useful for decision-making as well as medical interventions. The mo...
متن کاملReview of Natural History, Benefits and Risk Factors Pediatric Liver Transplantation
Liver or hepatic transplantation (LT) is the replacement of a diseased liver with part or whole healthy liver from another person (allograft). Human liver transplants were first performed by Thomas Starzl in the United States and Roy Calne in Cambridge, England in 1963 and 1967, respectively. Liver transplantation is a viable treatment option for end-stage liver disease and acute liver failure....
متن کاملRecurrence of fatty liver disease following liver transplantation for NAFLD-related cirrhosis: Current status and challenges
Non-alcoholic fatty liver disease (NAFLD) is emerging as a major health problem worldwide. NAFLD is a continuum of disease ranging from mild liver steatosis to severe steatohepatitis, which will ultimately lead to end-stage liver disease with high morbidity and mortality rates. This disorder is considered as a silent liver disease. The metabolic syndrome and its components are accounted as the ...
متن کاملRecent Technological Advances in Hepatogenic Differentiation of Stem Cells Relevant to Treatment of Liver Diseases
Liver failure, in an acute or chronic form, is a growing health problem ranking as one of the leading causes of death worldwide. Inborn errors of metabolism characterized by defects in hepatic enzymes or other proteins with metabolic functions, such as receptors or transporters accompanied with environmental factors involve etiology and presentation of liver failure. Currently, the only establi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical medicine
دوره 2 4 شماره
صفحات -
تاریخ انتشار 2002